扩张型心肌病射血分数恢复后纵向应变仍具预后价值
该回顾性国际队列研究纳入206例非缺血性扩张型心肌病且LVEF由<40%恢复至>50%的患者,在LVEF恢复时测量绝对整体纵向应变(aGLS)并随访5.5±2.8年。aGLS与全因死亡相关(校正Cox模型HR 0.90,95%CI 0.91-0.99,p=0.048),aGLS正常(>18%)者无死亡,aGLS<16%者死亡率更高(HR 3.2,95%CI 1.1-9,p=0.03)。
要点
- LVEF恢复正常的NICM患者中,aGLS受损常见且与随访死亡相关。
- aGLS>18%者随访期间无死亡,提示应变正常或可低危分层。
- aGLS<16%与更高死亡风险相关,HR 3.2(95%CI 1.1-9,p=0.03)。
核心结论
- 在LVEF恢复正常的NICM患者中,LVEF恢复时aGLS受损频繁且与随访期更差结局相关。
研究设计与样本
- 回顾性、国际、纵向队列研究,纳入LVEF<40%后恢复至正常范围(>50%)的NICM患者206例。
- 中位年龄53.5岁(IQR 44.3-62.8),男性占56.6%。
主要发现
- 诊断时LVEF为32.0%(IQR 24.0-38.8),恢复时LVEF为55.0%(IQR 51.7-60.0)。
- LVEF恢复时aGLS为13.6%±3.9%;166例(80%)aGLS≤18%,141例(68%)aGLS<16%。
- 随访5.5±2.8年期间35例(17%)死亡。
- 校正Cox模型中aGLS与随访死亡相关(HR 0.90,95%CI 0.91-0.99,p=0.048)。
- 未校正Kaplan-Meier分析中aGLS<16%与更高死亡相关(31例死亡(22%)vs 4例(6.2%),HR 3.2,95%CI 1.1-9,p=0.03)。
关键数值与推荐
- aGLS>18%定义为正常,aGLS≥16%视为具有潜在预后价值。
- aGLS正常(>18%)患者中未观察到死亡。
临床怎么用
- 对LVEF恢复正常的NICM患者,可在LVEF恢复时测量aGLS以辅助风险分层。
- aGLS<16%提示随访死亡风险较高,或需更密切监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with non-ischaemic dilated cardiomyopathy (NICM) may experience a normalisation in left ventricular ejection fraction (LVEF). Although this correlates with improved prognosis, it does not correspond to a normalisation in the risk of death during follow-up. Currently, there are no tools to risk stratify this population. We tested the hypothesis that absolute global longitudinal strain (aGLS) is associated with mortality in patients with NICM and recovered ejection fraction (LVEF). METHODS: We designed a retrospective, international, longitudinal cohort study enrolling patients with NICM with LVEF <40% improved to the normal range (>50%). We studied the relationship between aGLS measured at the time of the first recording of a normalised LVEF and all-cause mortality during follow-up. We considered aGLS >18% as normal and aGLS ≥16% as of potential prognostic value. RESULTS: 206 patients met inclusion criteria. Median age was 53.5 years (IQR 44.3-62.8) and 56.6% were males. LVEF at diagnosis was 32.0% (IQR 24.0-38.8). LVEF at the time of recovery was 55.0% (IQR 51.7-60.0). aGLS at the time of LVEF recovery was 13.6%±3.9%. 166 (80%) and 141 (68%) patients had aGLS ≤18% and <16%, respectively. During a follow-up of 5.5±2.8 years, 35 patients (17%) died. aGLS at the time of first recording of a recovered LVEF correlated with mortality during follow-up (HR 0.90, 95% CI 0.91 to 0.99, p=0.048 in adjusted Cox model). No deaths were observed in patients with normal aGLS (>18%). In unadjusted Kaplan-Meier survival analysis, aGLS <16% was associated with higher mortality during follow-up (31 deaths (22%) in patients with GLS <16% vs 4 deaths (6.2%) in patients with GLS ≥16%, HR 3.2, 95% CI 1.1 to 9, p=0.03). CONCLUSIONS: In patients with NICM and normalised LVEF, an impaired aGLS at the time of LVEF recovery is frequent and associated with worse outcomes.
引用
- Merlo M, Masè M, Perry A, et al. Prognostic significance of longitudinal strain in dilated cardiomyopathy with recovered ejection fraction. Heart. 2021. PMID: 34493546. doi:10.1136/heartjnl-2021-319504
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。